Published 1 hour ago • loading... • Updated 1 hour ago
Equatorial Guinea is expanding an ambitious malaria elimination plan
The plan pairs indoor spraying, nets and a new childhood vaccine with $116 million in funding to extend Bioko’s gains beyond the island.
Equatorial Guinea recently announced a $116 million investment to expand its malaria elimination program from Bioko Island to the mainland and Annobon, aiming to replicate success that reduced child deaths by 78%.
The program's success on Bioko relied on two decades of data collection and over $130 million in funding from ConocoPhillips and Chevron Oil alongside government support. Expanding to the mainland presents challenges, including porous borders with Cameroon and Gabon.
Using the WHO-recommended R21 vaccine, authorities plan to vaccinate 300,000 children while deploying drones to identify mosquito hotspots. Program coordinator Cristina Ngui Otogo emphasized that data-driven interventions allow real-time tracking of effectiveness.
Eliminating malaria is essential to attract tourists and ensure economic growth, according to Health Minister Mitoha Ondo'o Ayekaba. Malaria remains a disease of rural poverty, requiring better housing and healthcare infrastructure to be effectively fought.
With African countries accounting for 95% of global malaria cases, experts warn the continent is unlikely to reach its 2030 elimination goal. Dr. Matthew M. Ippolito of Johns Hopkins School of Medicine noted that transmission patterns vary significantly, complicating continental efforts.